The TNF-ligand and receptor superfamilies: Controllers of immunity and the Trojan Horses of autoimmune disease?

Molecular Aspects of Medicine

Volumn 17, Issue 5, 1996, Pages 455-457

  Hill, Colin Mitchell ^a,b   Lunec, Joseph ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Bath Institute for Rheumatic Diseases   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD30 ANTIGEN; CD40 ANTIGEN; FAS ANTIGEN; LIGAND; LYMPHOTOXIN; MEMBRANE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

AUTOIMMUNITY; B LYMPHOCYTE; HUMAN; IMMUNITY; IMMUNOPATHOLOGY; IMMUNOTHERAPY; PROTEIN FAMILY; PROTEIN SECRETION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0030267934     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(96)00011-8     Document Type: Review

References (229)

1. Abbas, A. K., Lichtman, A. H. and Pober, J. S. (1991a). Section III: Effector mechanisms of immune responses. In: Cellular and Molecular Immunology. W.B. Saunders & Co., London, 226 pp.
2. Abbas, A. K., Lichtman, A. H. and Pober, J. S. (1991b). Section I: General properties of immune responses. In Cellular and Molecular Immunology. W.B. Saunders & Co., London, 226 pp.
3. Adachi, M., Watanabe-Fukunaga, R. and Nagat, S. (1993). Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90, 1756.
4. Adams, L. E., Balakrishnan, K. and Roberts, S. M. (1993). Genetic, immunologic and biotransformation studies of patients on procainamide. Lupus 2, 89.
5. Adams, L. E., Roberts, S. M. and Carter, J. M. (1990). Effects of procainamide hydroxylamine on generation of reactive oxygen species by macrophages and production of cytokines. Int. J. Immunopharm. 12, 809.
6. Adams, L. E., Sanders, C. E. and Budinsky, R. A. (1989). Immunomodulatory effects of procainamide metabolites: Their implications in drug-related lupus. J. Lab. Clin. Med. 113, 482.
7. Aderka, D., Engelmann, H., Hornik, V., Skornick, Y., Levo, Y., Wallach, D. and Kushtai, G. (1991). Increased serum levels of soluble receptors for tumour necrosis factor in cancer patients. Cancer Res. 51, 5602.
8. Aderka, D., Engelmann, H., Maor, Y., Brakenbusch, C. and Wallach, D. (1992). Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors. J. Exp. Med. 175, 323.
9. Aderka, D., Wysenbeek, A., Engelmann, H., Cope, A. P., Brennan, F. M., Molad, F. Y., Hornick, V., Levo, Y., Maini, R. N., Feldmann, M. and Wallach, D. (1993). Correlation between serum levels of soluble tumour necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum. 36, 1111.
10. Agematsu, K., Kobata, T., Sugita, K., Freeman, G. J., Beckmann, M. P., Schlossman, S. F. and Morimoto, C. (1994). Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. J. Immunol. 153, 1421.
11. Alderson, M. R., Armitage, R. J., Marakovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F. and Lynch, D. H. (1993). Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178, 2231.
12. Alderson, M. R., Smith, C. A., Tough, T. W., Davis-Smith, T., Armitage, R. J., Falk, B., Roux, E., Baker, E., Sutherland, G. R., Din, W. S. and Goodwin, R. G. (1994). Molecular and biological characterisation of human 4-1BB and its ligand. Eur. J. Immunol. 24, 2219.
13. Allen, R. D., Marshall, J. D., Roths, J. B. and Sidman, C. L. (1990). Differences defined by bone marrow transplantation suggests that the lpr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp. Med. 172, 1367.
14. Alzona, M., Jack, H.-M., Fisher, R. and Ellis, T. M. (1994). CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 153, 2861.
15. Andreesen, R., Brugger, W., Lohr, G. W. and Bross, K. J. (1989). Human macrophages can express the Hodgkin's cell associated antigen Ki-1 (CD30). Am. J. Pathol. 134, 187.
16. Andrews, B. S., Eisenberg, E. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J., Murphy, E. D., Roths, J. B. and Dixon, F. J. (1978). Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148, 1198.
17. Armitage, R. J. (1994). Tumour necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6, 407.
18. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., MacDuff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., Clark, E. A., Smith, C. A., Grabstein, K. H., Cosman, D. and Spriggs, M. K. (1992). Molecular and biological characterisation of a murine ligand for CD40. Nature 357, 80.
19. Armitage, R. J., Tough, T. W., MacDuff, B. M., Fanslow, W. C., Spriggs, M. K., Ramsdell, F. and Alderson, M. A. (1993). CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23, 2326.
20. Aversa, G., Punnonen, J. and de Vries, J. E. (1993). The 26-kD transmembrane from tumour necrosis factor α on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177, 1575.
21. Baens, M., Chaffanet, M., Cassiman, J.-J., van den Berghe, H. and Marynon, P. (1993). Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16, 214.
22. Banner, D. W., D'Arcy, A., James, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H. and Lesslauer, W. (1993). Crystal structure of the soluble human 55 kD TNF-receptor-human TNF-β complex: Implications for TNF receptor activation. Cell 73, 431.
23. Barrett, T. B., Shu, G. and Clark, E. A. (1991). CD40 signalling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146, 1722.
24. Baud, L., Oudinet, J. P., Bens, M., Noe, L., Peraldi, M. N., Rondeau, E., Ettienne, J. and Ardaillou, R. (1989). Production of tumour necrosis factor by rat mesengial cells in response to bacterial lipopolysaccharide. Kidney Int. 35, 1111.
25. Baum, P. R., Gayle, R. B., Ramsdell, F., Srinivasan, S., Sorensen, R. A., Watson, M. L., Seldin, M. F., Baker, E., Sutherland, G. R., Clifford, K. N., Alderson, M. R., Goodwin, R. G. and Fanslow, W. C. (1994). Molecular characterisation of murine and human OX40/OX40L systems: Identification of a human OX40 ligand as the HTLV-1 regulated protein gp34. EMBO J. 13, 3992.
26. Bertolini, D. R., Newdin, G. E., Bringmann, T. S., Smith, D. D. and Mundy, G. R. (1988). Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factor. Nature 319, 516.
27. Beutler, B. (1992). Tumour Necrosis Factors: The Molecules and their Emerging Role in Medicine. Raven Press, New York.
28. Beutler, B. and Cerami, A. (1988). Tumour necrosis, cachexia, shock and inflammation: A common mediator. Annu. Rev. Biochem. 57, 505.
29. Beutler, B. and Cerami, A. (1989). The biology of cachectin/TNF - A primary mediator of the host response. Annu. Rev. Immunol. 7, 625.
30. Bjorck, P., Elenstrom-Magnusson, C., Roseen, A., Severinson, E. and Pauline, S. (1993). CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur. J. Immunol. 23, 1771.
31. Boussiotis, V. A., Nadler, L. M., Strominger, J. L. and Goldfield, A. E. (1994). Tumour necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc. Natl. Acad. Sci. USA 91, 7007.
32. Bowman, M. R., Crimmins, M. A. V., Yetz-Aldape, J., Kritz, R., Kelleher, K. and Herrmann, S. (1994). The cloning of CD70 and its identification as the ligand for CD27. J. Immunol. 152, 1756.
33. Bradshaw, R. A., Blundell, T. L., Lapatto, R. and McDonald, N. Q. (1993). Nerve growth factor revisisted. Trends Biochem. Sci. 18, 48.
34. Brennan, D. C., Yui, M. A., Wuthrich, R. P. and Kelley, V. E. (1989). Tumour necrosis factor and IL-1 in New Zealand black/white mice: Enhanced gene expression and acceleration of renal injury. J. Immunol. 143, 3470.
35. Brennan, F. M., Maini, R. N. and Feldmann, M. (1992). TNF-α: A pivotal role in rheumatoid arthritis? Br. J. Rheumatol. 31, 293.
36. Browning, J. L., Ngam-ek, A., Lawton, P., Demarinis, J., Tizard, R., Chow, E. P., Hession, C., O'Brien-Greco, B., Foley, S. F. and Ware, C. F. (1993). Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin at the cell surface. Cell 72, 847.
37. Calderhead, D. M., Buhlmann, J. E., van der Eertwegh, A. J. M., Claassen, E., Noelle, R. J. and Fell, H. P. (1993). Cloning of mouse OX40: A T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151, 5261.
38. Camerini, D., Walz, G., Loenen, W. A. M., Borst, J. and Seed, B. (1991). The T cell activation antigen CD27 is a member of the nerve growth factor/ tumour necrosis factor receptor gene family. J Immunol. 147, 3165.
39. Casciola-Roosen, L. A., Anhalt, G. and Rosen, A. (1994). Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317.
40. + lymphocytes. J. Immunol. 152, 1523.
41. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J. and Mountz, J. D. (1994). Protection from Fas mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759.
42. Chow, S. C., Weis, M., Kass, G. E. N., Holstrom, T. H., Erikkson, J. E. and Orrenius, S. (1995). Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett 364, 134.
43. Chu, J.-L., Drapa, J., Parnassa, A. and Elkon, K. B. (1993). The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon ETn. J. Exp. Med. 178, 723.
44. Chung, I. Y. and Benveniste, E. N. (1990). Tumour necrosis factor-α production by astrocytes. Induction by lipopolysaccharide, IFN-γ, and IL-1β. J. Immunol. 144, 2999.
45. Clark, E. A. and Lane, P. J. L. (1991). Regulation of human B cell activation and adhesion. Annu. Rev. Immunol. 9, 97.
46. Clark, E. A. and Ledbetter, J. A. (1994). How B and T cells talk to each other. Nature 367, 425.
47. Cohen, J. J., Duke, R. C., Fadok, V. A. and Sellins, K. S. (1992). Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol. 10, 267.
48. Cohen, P. L. and Eisenberg, R. A. (1991). Lpr and Gld - Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243.
49. Cope, A. P., Aderka, D., Doherty, M., Gibbons, D. L., Brennan, F. M., Maini, R. N., Wallach, D. and Feldmann, M. (1992). Soluble tumour necrosis factor (TNF) receptors are increased in the sera and synovial fluids of patients with rheumatic diseases. Br. J. Rheumatol. 31, 211.
50. Cosman, D. (1993). The haemopoietin receptor superfamily. Cytokine 5, 95.
51. Crowe, P. D., VanArsdale, T. L., Walter, B. N., Ware, C. F., Hession, C., Ehrenfels, B., Browning, J. L., Din, W. S., Goodwin, R. G. and Smith, C. A. (1994). A lymphotoxin-β specific receptor. Science 264, 707.
52. Dale, M. M., Foreman, J. C. and Fan, T.-P. D. (1994). Textbook of Immunopharmacology. Blackwell Scientific, London.
53. Daniel, P. T. and Krammer, P. H. (1994). Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 152, 5624.
54. Dealtry, G. B., Naylor, M. S., Fiers, W. and Balkwill, F. R. (1987). DNA fragmentation and cytotoxicity caused by tumour necrosis factor is enhanced by interferon-γ. Eur. J. Immunol. 17, 689.
55. Debatin, K.-M., Goldmann, C. K., Bamford, R., Waldmann, T. A. and Krammer, P. H. (1990). Monoclonal-antibody mediated apoptosis in adult T cell leukemia. Lancet 335, 497.
56. Deguchi, Y. and Kishimoto, S. (1991). Tumour necrosis factor cachectin plays a key role in autoimmune pulmonary inflammation in lupus-prone mice. Clin. Exp. Immunol. 85, 392.
57. H2 cytokines and HIV infection: A complex and fascinating link. Immunol. Today 16, 76.
58. + T cells producing Th2-type cytokines. FASEB J. 9, 81.
59. De Wit, D., Van Mechelen, M., Zanin, C., Doutrelepont, J. M., Velu, T., Gerard, C., Abramowicz, D., Scheerlinck, J. P., De Baetselier, P., Urbain, J., Leo, O., Goldman, M. and Moser, M. (1993). Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 150, 361.
60. Dorner, T., Matthias, H., Mayet, W. J., Trefzer, U., Burmester, G. R. and Hiepe, F. (1995). Enhanced membrane expression of the human Ro (SS-A0) and La (SS-B) antigens by human keratinocytes induced by TNFα. Ann. Rheum. Dis. 54, 904.
61. + thymocytes and activated mature lymphocytes in normal mice, but not in the lupus-prone strain. MRL lpr/lpr. Proc. Natl. Acad. Sci. USA 90, 10340.
62. Drexler, H. G., Jones, D. B., Diehl, V. and Minowada, J. (1989). Is the Hodgkin cell a T-or B-lymphocyte? Recent evidence from geno-and immunophenotypic analysis and in vitro cell lines. Haematol. Oncol. 7, 95.
63. Durkop, H., Latza, U., Hummel, M., Eitelbach, F., Seed, B. and Stein, H. (1992). Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68, 421.
64. Eck, M. J. and Sprang, S. R. (1989). The structure of tumour necrosis factor-α at 2·6A resolution. Implications for receptor binding. J. Biol Chem. 264, 17595.
65. Eck, M. J., Ultsch, M., Rinderknecht, E., de Vos, A. M. and Sprang, S. R. (1992). The structure of human lymphotoxin (tumour necrosis factor-β) at 1·9A resolution. J. Biol. Chem. 267, 2119.
66. Elkon, K. B. (1994). Apoptosis in SLE - Too little or too much? Clin. Exp. Rheum. 12, 553.
67. Ellis, R. E., Yuan, J. and Horvitz, H. R. (1991). Mechanisms and functions of cell death. Ann. Rev. Cell Biol. 7, 663.
68. + T cells. J. Immunol. 151, 2380.
69. Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D. and Wallach, D. (1989). A tumour necrosis factor binding protein purified to homogeneity from human urine protects cells from tumour necrosis factor toxicity. J. Biol. Chem. 264, 11974.
70. Engelmann, H., Novick, D. and Wallach, D. (1990). Two tumour necrosis factor binding proteins purified from human urine. Evidence for immunological cross reactivity with cell surface tumour necrosis factor receptors. J. Biol. Chem. 265, 1531.
71. Falk, M. H., Trauth, B. C., Debatin, K.-M., Klas, C., Gregory, C. D., Rickinson, A. B., Calender, A., Lenoir, G. M., Ellwart, J. W., Krammer, P. H. and Bornkamm, G. W. (1992). Expression of APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift toward lymphoblastoid phenotype. Blood 79, 3300.
72. Farrah, T. and Smith, C. A. (1992). Emerging cytokine family. Nature 358, 26.
73. Fehsel, K., Kolb-Bachofen, V. and Kolb, H. (1991). Analysis of TNF-α-induced DNA strand breaks at the single cell level. Am. J. Pathol. 139, 251.
74. Froese, P., Lemke, H., Gerdes, J., Havsteen, B., Schwarting, R., Hansen, H. and Stein, H. (1987). Biochemical characterisation and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus transformed human B and T lymphoid cell lines. J. Immunol. 139, 2081.
75. Galy, A. H. M. and Spits, H. (1992). CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149, 775.
76. Garrett, I. R., Durie, B. G. M., Nedwin, G. E., Gillespie, A., Bringman, T., Sabatini, M., Bertolini, D. R. and Mundy, G. R. (1987). Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N. Engl. J. Med. 317, 526.
77. Gauchat, J.-F., Henchoz, S., Mazzei, G., Aubry, J.-P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores-Romo, L., Thompson, J., Kishi, K., Butterfield, J., Dahinden, C. and Bonnefoy, J.-Y. (1993). Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340.
78. Godding, L. R. (1992). Virus proteins that counteract host immune defences. Cell 71, 5.
79. + T cells with homology to tumour necrosis factor. J. Exp. Med. 180, 757.
80. Goodwin, R. G., Alderson, M. R., Smith, C. A., Armitage, R. J., VandenBos, T., Jerzy, R., Tough, T. W., Schoenborn, M. A., Davis-Smith, T., Hennen, K., Falk, B., Cosman, D., Baker, E., Sutherland, G. R., Grabstein, K. H., Farrah, T., Giri, J. G. and Beckmann, M. P. (1993a). Molecular and biological characterisation of a ligand for CD27 defines a new family of cytokines with homology to tumour necrosis factor. Cell 73, 447.
81. Goodwin, R. G., Din, W. S., Davis-Smith, T., Anderson, D. M., Gimpel, S. D., Sato, T. A., Maliszewski, C. R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., Farrah, T., Armitage, R. J., Fanslow, W. C. and Smith, C. A. (1993b). Molecular cloning of a ligand for the inducible T-cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumour necrosis factor. Eur. J. Immunol. 23, 2631.
82. Gordon, C., Ranges, G. E., Greenspan, J. S. and Wofsy, D. (1989). Chronic therapy with recombinant tumour necrosis factor-α in autoimmune NZB/NZW F1 mice. Clin. Immunol. Immunopathol. 52, 42.
83. Gordon, C. and Wofsy, D. (1990). Effects of recombinant tumour necrosis factor-α on immune function. J. Immunol. 144, 1753.
84. Gordon, J. R. and Galli, S. J. (1990). Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346, 274.
85. Gruss, H.-J. and Dower, S. K. (1995). Tumour necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85, 3378.
86. Gruss, H.-J., Boiani, N., Williams, D. E., Armitage, R. J., Smith, C. A. and Goodwin, R. G. (1994). Pleitropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83, 2045.
87. Gruss, H.-J., DaSilva, N., Hu, Z.-B., Uphoff, C. C., Goodwin, R. G. and Dexler, H. G. (1994). Expression and regulation of CD30 ligand and CD30 in human leukemic-lymphoma cell lines. Leukemia 8, 2083.
88. Gruss, H.-J., Hirschstein, D., Alderson, M. A. and Armitage, R. J. (1995). Regulation of CD30 ligand expression on peripheral blood T cells: Functional involvement in T-T cell interaction. J. Immunol. 155.
89. Handwerger, B. S., Rus, V., Silva, L. da and Via, C. S. (1995). The role of cytokines in the immunopathogenesis of lupus. In: Systemic Lupus Erythematosus (P. A. Meischer, ed.), p. 23. Springer, London.
90. Hecht, T. T., Longo, D. L., Cossman, J., Bolen, J. B., Hsu, S. M., Israel, M. and Fisher, R. I. (1985). Production and characterisation of a monoclonal antibody that binds Reed-Sternberg cells. J. Immunol. 134, 4231.
91. Heilig, B., Fiehn, C., Brockhaus, M., Gallati, H., Pezzutto, A. and Hunstein, W. (1993). Evaluation of soluble tumour necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematosis, progressive systemic sclerosis, and mixed connective tissue disease. J. Clin. Immunol. 13, 321.
92. Heller, R. A. and Kronke, M. (1994). Tumour necrosis factor receptor mediated signalling pathways. J. Cell Biol. 126, 5.
93. Herron, L. R., Eisenberg, R. A., Roper, E., Kakkanaiah, V. N., Cohen, P. L. and Kotzin, B. L. (1993). Selection of the T cell repertoire in Lpr mice. J. Immunol. 151, 3450.
94. Hill, C. M., Lunec, J., Griffiths, H. R. and Herbert, K. H. (1995). Characterisation of tumour necrosis factor α release by human granulocytes in response to procainamide challenge. Biochem. Pharmacol. 49, 1837.
95. Hintzen, R. Q., de Jong, R., Hack, C. E., Chamuleau, M., de Vries, E. F. R., Borst, J. and van Lier, R. A. (1991a). A soluble form of the T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J. Immunol. 147, 29.
96. Hintzen, R. Q., de Jong, R., Lens, S. M. A. and van Lier, R. A. (1994b). CD27: Marker and mediator of T-cell activation? Immunol. Today 15, 307.
97. Hintzen, R. Q., Lens, S. M. A., Koopman, G., Pals, S. T., Spits, H. and VanLier, R. A. W. (1994a). CD70 represents the human ligand for CD27. Int. Immunol. 6, 477.
98. Hintzen, R. Q., van Lier, R. A., Kuijpers, K. C., Baars, P. A., Schaasberg, W., Lucas, C. J. and Polman, C. H. (1991b). Elevated levels of a soluble form of the T cell activation antigen in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 35, 211.
99. Horwitz, D. A. and Jacob, C. O. (1995). The cytokine network in the pathogenesis of systemic lupus erythematosus, and possible therapeutic applications. In: Systemic Lupus Erythematosus (P. A. Meischer, ed.), p. 51. Springer, London.
100. Howard, O. M. Z., Clouse, K. A., Smith, C., Goodwin, R. G. and Farrar, W. L. (1993). Soluble tumour necrosis factor receptor: Inhibition of human immunodeficiency virus activation. Proc. Natl. Acad. Sci. USA 90, 2335.
101. Howard, S. T., Chan, Y. S. and Smith, G. L. (1991). Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumour necrosis factor receptor family. Virology 180, 633.
102. Hu, F.-Q., Smith, C. A. and Pickup, D. J. (1994). Cowpox contains two copies of an early encoding soluble secreted form of the type II TNF receptor. Virology 204, 343.
103. 1 mice. J. Exp. Med. 179, 305.
104. Itoh, N. and Nagata, S. (1993). A novel protein domain required for apoptosis: Mutational analysis of human Fas antigen. J. Biol. Chem. 268, 932.
105. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233.
106. Jacob, C. O. (1992). Studies on the role of tumour necrosis factor in murine and human autoimmunity. J. Immunol. 5, 133.
107. Jacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A. and McDevitt, H. O. (1990). Heritable major histocompatibility complex class II-associated differences in production of tumour necrosis factor in mice and humans: Relevance to the pathogenesis of autoimmune diseases. Immunol. Res. 10, 156.
108. Jacob, C. O., Hwang, F., Lewis, G. D. and Stall, A. M. (1992). Tumour necrosis factor-α in murine systemic lupus erythematosus disease models: Implications for genetic predisposition and immune regulation. Cytokine 3, 551.
109. Jacob, C. O. and McDevitt, H. O. (1988). Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis. Nature 331, 356.
110. Johnson, D., Lanahan, A., Buck, C. R., Sehgal, A., Morgan, C., Mercer, E., Bothwell, M. and Chao, M. (1986). Expression and structure of the human NGF receptor. Cell 47, 545.
111. Jones, E. Y., Stuart, D. I. and Walker, N. P. (1990). The three-dimensional structure of tumour necrosis factor. Prog. Clin. Biol. Res. 349, 321.
112. Josimovic-Alasevic, O., Durkop, H., Schwarting, R., Backe, E., Stein, H. and Diamantstein, T. (1989). Ki-1 (CD30) antigen is released by Ki-1-positive tumour cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. Eur. J. Immunol. 19, 157.
113. Kehrl, J. H., Alvarez-Mon, M., Delsing, G. A. and Fauci, A. S. (1987). Lymphotoxin is an important T cell-derived growth factor for human B cells. Science 238, 1144.
114. Kennedy, M. K., Mohler, K. M., Shanebeck, K. D, Baum, P. R., Picha, K. S., Otten-Evans, C. A., Janeway, C. A. Jr. and Grabstein, K. H. (1994). Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24, 116.
115. Keshav, S., Lawson, I., Chung, I. P., Stein, M., Perry, V. H. and Gordon, S. (1990). Tumour necrosis factor messenger RNA localised to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J. Exp. Med. 164, 1350.
116. cg. Clin. Exp. Immunol. 79, 123.
117. Kishimoto, T., Taga, T. and Akira, S. (1994). Cytokine signal transduction. Cell 76, 253.
118. Klimas, N. G., Patarca, R., Perez, G., Garciamorales, R., Schultz, D., Schabel, J. and Fletcher, M. A. (1992). Case report: Distinctive immune abnormalities in a patient with procainamide-induced lupus and serositis. Am. J. Med. Sci. 303, 99.
119. Knapp, W., Dorken, B., Rieber, E. P., Stein, H., Gilks, W. R., Schmidt, R. E. and Kr. von dem Borne, A. E. G. (1989). Leukocyte Typing IV: White Cell Differentiation Antigens. Oxford University Press, Oxford.
120. Kobayashi, N., Hamamoto, Y., Yamamoto, N., Ishii, A., Yonehara, M. and Yonehara, S. (1990). Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Natl. Acad. Sci. USA 87, 9620.
121. Kock, A., Schwarz, T., Kirnbauer, R., Urbanski, A., Perry, P., Ansel, J. C. and Luger, T. A. (1990), Human keratinocytes are a source of tumour necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172, 1609.
122. Kohno, T., Brewer, M. T., Baker, S. L., Schwartz, P. E., King, M. W., Hale, K. K., Squires, C. H., Thompson, R. C. and Vannice, J. L. (1990). A second tumor necrosis factor receptor gene product can shed a naturally occurring tumour necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87, 8331.
123. Kriegler, M., Perez, C., DeFay, K., Albert, I. and Lu, S. D. (1988). A novel form of TNF/ cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF. Cell 53, 45.
124. Kwon, B. S. and Weissman, S. M. (1989). cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA 86, 1963.
125. Kwon, B. S., Kim, G. S., Prystowsky, M. B., Lancki, D. W., Sabath, D. E., Pan, J. L. and Weissman, S. M. (1987). Isolation and initial characterisation of multiple species of T-lymphocyte subset cDNA clones. Proc. Natl. Acad. Sci. USA 84, 2896.
126. Lahita, R. G. (ed.) (1987). Systemic Lupus Erythematosus. John Wiley and Sons, New York.
127. Lane, P., Brocker, T., Hubele, S., Padovan, E., Lanzavecchia, A. and McConnell, F. (1993). Soluble CD40 can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177, 1209.
128. Lantz, M., Gullberg, U., Nilsson, E. and Olsson, I. (1990). Characterisation in vitro of human tumour necrosis factor-binding protein. A soluble form of a tumour necrosis factor receptor. J. Clin. Invest. 86, 1396.
129. Laskov, R., Lanez, G., Ruddle, N. H., McGrath, K. M., Specter, S., Klein, T., Djeu, J. Y. and Friedman, H. (1990). Production of tumour necrosis factor (TNF-α) and lymphotoxic (TNF-β) by murine pre-B and B cell lymphomas. J. Immunol. 144, 3424.
130. Latza, U., Durkop, H., Schnittger, S., Ringeling, J., Eitelbach, F., Hummel, M., Fonatsch, C. and Stein, H. (1994). The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur. J. Immunol. 24, 677.
131. Loenen, W. A., de Vries, E. F. R., Gravestein, L. A., Hintzen, R. Q., van Lier, R. A. and Borst, J. (1992). The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur. J. Immunol. 22, 447.
132. Loetscher, H., Pan, Y.-C. E., Lahm, H.-W., Gentz, R., Brockhaus, M. P., Tahuchi, H. and Lesslauer, W. (1990). Molecular cloning and expression of the human 55 kD tumour necrosis factor receptor. Cell 61, 351.
133. Lynch, D. H. (1995). Biology of Fas. Circ. Shock 44, 163.
134. Magilavy, D. B. and Rothstein, J. L. (1988). Spontaneous production of tumour necrosis factor-α by Kuppfer cells of MRL/lpr mice. J. Exp. Med. 168, 789.
135. Maini, R. N., Elliott, M. J., Charles, P. J. and Feldmann, M. (1995). Immunological intervention reveals reciprocal roles for tumour necrosis factor-α and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus. In: Systemic Lupus Erythematosus (P.A. Meischer, ed.), p. 197. Springer, Berlin.
136. Malide, D., Russo, P. and Bendayan, M. (1995). Presence of tumour necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum. Pathol. 26, 558.
137. 1A molecule related to nerve growth factor receptor. EMBO J. 9, 1063.
138. Mallett, S. and Barclay, A. N. (1991). A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol. Today 12, 95.
139. + T cell clones in human immunodeficiency virus infection. J. Exp. Med. 180, 2407.
140. Marsters, S. A., Frutkin, A. D., Simpson, N. J., Fendly, B. M. and Ashkenazi, A. (1992). Identification of cysteine-rich domains of the type-I tumour necrosis factor receptor involved in ligand binding. J. Biol. Chem. 267, 5747.
141. + B lymphocyte subset. J. Immunol. 148, 3700.
142. Maurer, D., Holter, W., Majdic, O., Fischer, G. F. and Knapp, W. (1990). CD27 expression by a distinct subpopulation of human B lymphocytes. Eur. J. Immunol. 20, 2679.
143. McMichael, A. J. (1986). Leukocyte Typing III: White Cell Differentiation Antigens. Oxford University Press, Oxford.
144. Meijer, C., Huysen, V., Smeenk, R. T. J. and Swaak, A. J. G. (1993). Profiles of cytokines (TNF-α and IL-6) and acute phase proteins (CRP and α1 AG) related to the disease course in patients with systemic lupus erythematosus. Lupus 2, 359.
145. Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A. and Yuan, J. (1993). Induction of apoptosis in fibroblasts by IL-1β converting enzyme, a mammalian homologue of the, C. elegans cell death gene ced-3. Cell 75, 650.
146. Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Derwar, S. S., Torrance, D. S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., Kronheim, S. R., Petersen, M., Gerhart, M., Kozlosky, C. J., March, C. J. and Black, R. A. (1994). Protection against lethal endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370, 218.
147. Moller, P., Henner, C., Leithauser, F., Eichelmann, A., Schmidt, A., Bruderlein, S., Dhein, J. and Krammer, P. H. (1993). Co-regulation of the APO-1 antigen with ICAM-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle centre and mediastinal B cell lymphomas. Blood 81, 2067.
148. Mountz, J. D., Wu, J., Cheng, J. and Zhou, T. (1994). Autoimmune disease: A problem of defective apoptosis. Arthritis Rheum. 10, 1415.
149. lo thymocytes in vivo. Science 250, 1720.
150. Mysler, E., Bini, P., Drappa, J., Ramos, P., Friedman, S. M., Krammer, P. H. and Elkon, K. B. (1994). The APO-1/Fas protein in human systemic lupus erythematosus. J. Clin. Invest. 93, 1029.
151. Nagata, S. (1994). Fas and Fas ligand: A death factor and its receptor. Adv. Immunol. 57, 129.
152. Nagata, S. and Golstein, P. (1995). The Fas death factor. Science 267, 1449.
153. Nagata, S. and Suda, T. (1995). Fas and Fas Ligand: lpr and gld mutations. Immunol. Today 16, 39.
154. Naume, B., Shalaby, R., Lessauer, W. and Espevick, T. (1991). Involvement of the 55-and 75-kDa tumour necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. J. Immunol. 146, 3045.
155. Ochonisky, S. and Revuz, J. (1994). Thalidomide use in dermatology. Em. J. Dermatol. 4, 9.
156. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T. and Nagata, S. (1993). Lethal effect of anti-Fas antibody in mice. Nature 364, 806.
157. Owen-Schaub, L. (1993). Fas/APO-1: A cell surface protein mediating apoptosis. Canc. Bull 46, 141.
158. Parker, D. C. (1993). T cell-dependent B cell activation. Annu. Rev. Immunol. 11, 331.
159. Paterson, D. J., Jeffries, W. A., Green, J. R., Brandon, M. R., Corthesy, P., Puklavec, M. and Williams, A. F. (1987). Antigens of activated rat T lymphocytes including a molecule of 50,000M detected only on CD4 positive blasts. Mol. Immunol. 24, 1281.
160. Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B. and Goeddel, D. V. (1984). Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312, 724.
161. Pollok, K. E., Kim, Y.-J., Zhou, Z., Hurtado, J., Kim, K. K., Pickard, R. T. and Kwon, B. S. (1993). Inducible T cell antigen 4-1BB binds. Analysis of expression and function. J. Immunol. 150, 771.
162. Pollok, K. E., Kim, Y. J., Hurtado, J., Zhou, Z., Kim, K. K. and Kwon, B. S. (1994). 4-1BB T cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur. J. Immunol. 24, 367.
163. Porteu, F. and Nathan, C. (1990). Shedding of tumour necrosis factor receptors by activated human neutrophils. J. Exp. Med. 172, 599.
164. Raff, M. C. (1992). Social control on cell survival and cell death. Nature 356, 397.
165. Ranheim, E. A. and Kipps, T. J. (1993). Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177, 925.
166. Rose, L. M., Lathchman, D. S. and Isenberg, D. A. (1994). BCL-2 and FAS, molecules which influence apoptosis. A possible role in systemic lupus erythematosus? Autoimmunity 17, 271.
167. Roths, J. B., Murphy, E. D. and Eicher, E. M. (1984). A new mutation, gld that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159, 1.
168. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195.
169. Rubin, B. Y., Anderson, S. L., Sullivan, S. A., Williamson, B. D., Carswell, E. A. and Old, L. J. (1986). Nonhematopoietic cells selected for resistance to tumour necrosis factor produce tumour necrosis factor. J. Exp. Med. 164, 1350.
170. Russell, J. H., Rush, B., Weaver, C. and Wang, R. (1993). Mature T cells of autoimmune lpr/lpr mice have a defect in antigen stimulated suicide. Proc. Natl. Acad. Sci. USA 90, 4409.
171. Savill, J. (1995). Apoptosis and renal injury. Curr. Opin. Nephrol. Hypertens. 4, 263.
172. Sawada, M., Kondo, N., Suzumura, A. (1989). Marunouchi, T., Production of tumour necrosis factor-alpha by microglial astrocytes in culture. Brain. Res. 491, 394.
173. Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., Kohr, K. J. and Goeddle, D. V. (1990). Molecular cloning and expression of a receptor for human tumour necrosis factor. Cell 61, 361.
174. Schlegel, J., Peters, I. and Orrenius, S. (1995). Isolation and partial characterisation of a protease involved in Fas-induced apoptosis. FEBS Lett. 364, 139.
175. Schulze-Osthoff, K. (1994). The Fas/APO-1 receptor and its deadly ligand. Trends Cell Biol 4, 421.
176. Schwab, U., Stein, H., Gerdes, J., Lemke, H., Kirchner, H., Schaadt, M. and Diehl, V. (1982). Production of monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299, 65.
177. Schwarting, R., Gerdes, J., Durkop, H., Falini, B., Pileri, S. and Stein, H. (1989). A new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74, 1678.
178. Schwarz, H., Tuckwell, J. and Lotz, M. (1993). A receptor induced by lymphocyte activation (IIa) - A new member of the human nerve-growth factor receptor family. Gene 134, 295.
179. Seldin, M. F., Morse, H. C. Jr III, Reeves, J. P., Seribner, C. L., Le Boeuf, R. C. and Steinberg, A. D. (1988). Genetic analysis of autoimmune gld mice. I. Idntification of a restriction fragment length polymorphism closely linked to the gld mutation within a conserved linkage group. J. Exp. Med. 167, 688.
180. Shallaby, M. R., Sundan, A., Loetscher, H., Brockhaus, M., Lesslauer, W. and Espevick, T. (1990). Binding and regulation of cellular functions by monoclonal antibodies against human tumour necrosis factor receptors. J. Exp. Med. 172, 1517.
181. Singer, G. G. and Abbas, A. K. (1994). The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365.
182. Smith, C. A., Davis, T., Anderson, D., Solam, L., Beckmann, M. P., Jerzy, R., Dower, S. K., Cosman, D. and Goodwin, R. J. (1990). A receptor for tumour necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019.
183. Smith, C. A., Davis, T., Wignall, J. M., Din, W. S., Farrah, T., Upton, C., McFadden, G. and Goodwin, R. G. (1991). T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176, 335.
184. Smith, C. A., Farrah, T. and Goodwin, R. G. (1994). The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and death. Cell 76, 959.
185. Smith, C. A., Gruss, H.-J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G. R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., Grabstein, K. H., Gliniak, B., McAlister, I. B., Fanslow, W. C., Alderson, M., Falk, B., Gimpel, S., Gillis, S., Din, W. S., Goodwin, R. J. and Armitage, R. J. (1993). CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73, 1349.
186. Smith, G. L. (1993). Vaccinia virus glycoproteins and immune evasion. J. Gen. Virol. 74, 1725.
187. Smith, R. A. and Baglioni, C. (1987). The active form of tumour necrosis factor is a trimer. J. Biol. Chem. 262, 6951.
188. Sobel, E. S., Kakkanaiah, V. N., Cohen, P. L. and Eisenberg, R. A. (1993). Correlation of gld autoimmunity by coinfusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int. Immunol. 5, 1275.
189. Spriggs, D. R., Imamura, K., Rodriguez, C., Sariban, E. and Kufe, D. W. (1988). Tumour necrosis factor expression in human epithelial tumour cell lines. J. Clin. Invest. 81, 455.
190. Spriggs, M. K., Fanslow, W. C. and Smith, C. A. (1993). The biology of the human ligand for CD40. J. Clin. Immunol. 13, 373.
191. Stall, A. M., Farinas, M. C., Tarlinton, D. M., Lalor, P. A., Harzenberg, L. A. and Strober, S. (1988). Ly-1 B cell clones similar to human chronic lymphocytic leukemias routinely develop in older mice and young autoimmune (New Zealand Black related) animals. Proc. Natl. Acad. Sci. USA 85, 7312.
192. Stamenkovic, I., Clark, E. A. and Seed, B. (1989). A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8, 1403.
193. Steffen, M., Ottmann, O. and Moore, M. (1988). Simultaneous release of tumour necrosis factor-γ and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. J. Immunol. 140, 2621.
194. Stein, H., Mason, D. Y., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., Schwarting, R. and Lennert, K. (1985). The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66, 848.
195. Steller, H. (1995). Mechanisms and genes of cellular suicide. Science 267, 1445.
196. Strasser, A. (1995). Life and death during lymphocyte development and function: Evidence for two distinct killing mechanisms. Curr. Opin. Immunol. 7, 228.
197. Suda, T. and Nagata, S. (1994). Purification and characteristion of the fas-ligand that induces apoptosis. J. Exp. Med. 179, 873.
198. Suda, T., Takahashi, T., Golstein, P. and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumour necrosis factor family. Cell 75, 1169.
199. Sugita, K., Robertson, M. J., Torimoto, Y., Ritz, J., Schlossman, S. F. and Morimoto, C. (1992). Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J. Immunol. 149, 1199.
200. Sung, S., Bjorndahl, J., Wang, C., Kao, H. and Fu, S. (1988a). Production of tumour necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol mistate acetate and anti-CD3 antibody. J. Exp. Med. 167, 937.
201. Sung, S., Jung, L., Walters, J., Chen, W., Wang, C. and Fu, S. (1988b). Production of tumour necrosis factor/cachectin by human B cell lines and tonsillar B cells. J. Exp. Med. 168, 1539.
202. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. (1994). Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76, 969.
203. Tartaglia, L. A., Ayers, T. M., Wong, G. H. W. and Goeddel, D. V. (1993a). A novel domain within the 55 kD TNF receptor signals cell death. Cell 74, 845.
204. Tartaglia, L. A., Rothe, M., Hu, Y.-F. and Goeddel, D. V. (1993b). Tumour necrosis factor's cytotoxic activity is signalled by the p55 TNF receptor. Cell 73, 213.
205. Theofilopoulos, A. N. and Dixon, F. J. (1985). Murine models of systemic lupus erythematosus. Adv. Immunol. 37, 269.
206. Trauth, B. C., Klas, C., Peters, A. M. J., Matzuku, S., Moller, P., Falk, W., Debatin, K. M. and Krammer, P. H. (1989). Monoclonal antibody-mediated tumour regression by induction of apoptosis. Science 245, 301.
207. Tsai, C. Y., Wu, T. H., Huang, S. F, Sun, K. H., Hsieh, S. C., Han, S. H., Yu, H. S. and Yu, C. L. (1995). Abnormal splenic and thymic IL-4 and TNF-alpha expression in MRL-lpr/lpr mice. Scand. J. Immunol. 41, 157.
208. Uckun, F. M., Gajl-Peczalska, K., Meyers, D. E., Jasczc, W., Haissig, S. and Ledbetter, J. A. (1990). Temporal association of CD40 antigen expression with discrete stages of human B cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage non-Hodgkin's lymphoma cells. Blood 76, 2449.
209. Upton, C., Macen, J. L., Schreiber, M. and McFadden, G. (1991). Myxoma virus expresses a secreted protein with homology to the tumour necrosis factor receptor gene family that contributes to viral virulence. Virology 184, 370.
210. van Koeten, C., Gaillard, C., Galizzi, J.-P., Hermann, P., Fossiez, F., Banchereau, J. and Blanchard, D. (1994). B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 24, 787.
211. van Lier, R. A., Borst, J., Vroom, T. M., Klein, H., van Mourik, P., Zeijlemaker, W. P. and Melief, C. J. M. (1987). Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139, 1589.
212. + T cell subset. Eur. J. Immunol. 18, 811.
213. Vassilli, P. (1992). The pathophysiology of tumour necrosis factors. Annu. Rev. Immunol. 10, 411.
214. Vaux, D. L. (1993). Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA 90, 786.
215. Warner, S. J. C. and Libby, P. (1989). Human vascular smooth muscle cells. Target for and source of tumour necrosis factor. J. Immunol. 42, 100.
216. Watanabe, T., Sakai, Y., Miyawaki, S., Shimizu, A., Koiwai, O. and Ohno, K. (1991). A molecular genetic linkage map of mouse chromosome-19, including lpr, Ly-44, and TdT genes. Biochem. Genet. 29, 325.
217. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S. (1992b). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314.
218. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A. and Nagata, S. (1992a). The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274.
219. Williams, A. F. and Barclay, A. N. (1988). The immunoglobulin superfamily-domains for cell surface recognition. Ann. Rev. Immunol. 6, 381.
220. Wilson, A. G., Gordon, C., Di Giovine, F. S., De Vries, N., Van de Putte, L. B. A., Emery, P. and Duff, G. W. (1994). A genetic association between systemic lupus erythematosus and tumour necrosis factor alpha. Eur. J. Immunol. 24, 191.
221. Wong, G. H. W. and Goeddel, D. V. (1994). Fas antigen and the p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152, 1751.
222. Wu, J., Zhou, T., He, J. and Mountz, J. D. (1993). Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178, 461.
223. Wyllie, A. H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555.
224. Yellin, M. J., Sinning, J., Covey, L. R., Sherman, W., Lee, J. J., Glickman-Nir, E., Sippel, K. C., Rogers, J., Cleary, A. M., Parker, M., Chess, L. and Lederman, S. (1994). T lymphocyte T cell-B-cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J. Immunol. 153, 666.
225. Yokoyama, H., Kreft, B. and Kelley, V. R. (1995). Biphasic increases in circulating and renal TNF-α in MRL-lpr mice with differing regulatory mechanisms. Kidney Int. 47, 122.
226. Yonehara, S., Ishii, A. and Yonehara, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumour necrosis factor. J. Exp. Med. 169, 1747.
227. β8 TCR transgenic LPR mice. FASEB J. 5, A645.
228. Zhou, T., Wu, J. G. and Mountz, J. D. (1992). Defective expression of the fas apoptosis antigen RNA in thymus and lymph-node of MRL-lpr/lpr mice leads to abnormal T cells. Arthritis Rheum. 35 (Supp.), S155.
229. Zhou, T., Bluehmann, H., Eldridge, J., Berry, K. and Mountz, J. D. (1993). Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. J. Immunol. 150, 3651.